Vascular dementia;Vasculaire dementie

Nederlands Tijdschrift voor Geneeskunde

Volumn 148, Issue 24, 2004, Pages 1181-1186

  De Leeuw, F E ^a,b   Van Gijn, J ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^b UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; CHOLINESTERASE INHIBITOR;

ATHEROSCLEROSIS; BRAIN RADIOGRAPHY; CEREBROVASCULAR DISEASE; CLINICAL FEATURE; COGNITIVE DEFECT; DISEASE COURSE; EPIDEMIOLOGICAL DATA; HIGH RISK POPULATION; HUMAN; HYPERTENSION; INCIDENCE; MULTIINFARCT DEMENTIA; POPULATION RESEARCH; PREVALENCE; PRIMARY PREVENTION; REVIEW; RISK ASSESSMENT; RISK FACTOR; SECONDARY PREVENTION;

AGED; AGED, 80 AND OVER; ARTERIOSCLEROSIS; ASPIRIN; CEREBROVASCULAR ACCIDENT; CYCLOOXYGENASE INHIBITORS; DEMENTIA, VASCULAR; FEMALE; HUMANS; HYPERTENSION; MALE; PREVALENCE; RISK FACTORS;

EID: 3042589484     PISSN: 00282162     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (22)

1. Zandvoort MJ van, Kappelle W, Algra A, Haan EH de. Decreased capacity for mental effort after single supratentorial lacunar infarct may affect performance in everyday life. J Neurol Neurosurg Psychiatry 1998;65:697-702.
2. Tatemichi TK, Desmond DW, Mayeux R, Paik M, Stern Y, Sano M, et al. Dementia after stroke, baseline frequency, risks, and clinical features in a hospitalized cohort. Neurology 1992;42:1185-93.
3. Ott A, Breteler MMB, Harskamp F van, Claus JJ, Cammen TJ van der, Grobbee DE, et al. Prevalence of Alzheimer's disease and vascular dementia: association with education. The Rotterdam study. BMJ 1995;310:970-3.
4. Ruitenberg A, Ott A, Swieten JC van, Hofman A, Breteler MMB. Incidence of dementia, does gender make a difference? Neurobiol Aging 2001;22:575-80.
5. Ruitenberg A. Vascular factors in dementia [proefschrift]. Rotterdam: Erasmus Universiteit Rotterdam; 2000.
6. Hofman A, Ott A, Breteler MMB, Bots ML, Slooter AJ, Harskamp F van, et al. Atherosclerosis, apolipoprotein E, and prevalence of dementia and Alzheimer's disease in the Rotterdam study. Lancet 1997;349:151-4.
7. Censori B, Manara O, Agostinis C, Camerlingo M, Casto L, Galavotti B, et al. Dementia after first stroke. Stroke 1996;27:1205-10.
8. Shepherd J, Blauw GJ, Murphy MB, Bollen EL, Buckley BM, Cobbe SM, et al. PROSPER study group. PROspective Study of Pravastatin in the Elderly at Risk. Pravastatin in elderly individuals at risk of vascular disease (PROSPER). Lancet 2002;360:1623-30.
9. World Health Organization (WHO). The neurological adaptation of the International Classification of Diseases (ICD IO). Genève: WHO; 1991.
10. Bennett DA, Gilley DW, Lee S, Cochran EJ. White matter changes: neurobehavioral manifestations of Binswanger's disease and clinical correlates in Alzheimer's disease. Dementia 1994;5:148-52.
11. Groot JC de, Leeuw FE de, Oudkerk M, Gijn J van, Hofman A, Jolles J, et al. Cerebral white matter lesions and cognitive function: the Rotterdam scan study. Ann Neurol 2000;47:145-51.
12. Gijn J van. White matters, small vessels and slow thinking in old age. Lancet 2000;356:612-3.
13. Hennerici MG, Oster M, Cohen S, Schwartz A, Motsch L, Daffertshofer M. Are gait disturbances and white matter degeneration early indicators of vascular dementia? Dementia 1994;5:197-202.
14. Tarvonen-Schroder S, Roytta M, Raiha I, Kurki T, Rajala T, Sourander L. Clinical features of leuko-araiosis. J Neurol Neurosurg Psychiatry 1996;60:431-6.
15. Groot JC de, Leeuw FE de, Oudkerk M, Hofman A, Jolles J, Breteler MMB. Cerebral white matter lesions and depressive symptoms in elderly adults. Arch Gen Psychiatry 2000;57:1071-6.
16. Roman GC, Tatemichi TK, Erkinjuntti T, Cummings JL, Masdeu JC, Garcia JH, et al. Vascular dementia: diagnostic criteria for research studies. Report of the NINDS-AIREN International Workshop. Neurology 1993;43:250-60.
17. Straaten EC van, Scheltens P, Knol DL, Buchem MA van, Dijk EJ van, Hofman PA, et al. Operational definitions for the NINDS-AIREN criteria for vascular dementia: an interobserver study. Stroke 2003;34:1907-12.
18. Veld BA in 't, Ruitenberg A, Hofman A, Stricker BH, Breteler MMB. Antihypertensive drugs and incidence of dementia: the Rotterdam study. Neurobiol Aging 2001;22:407-12.
19. Williams PS, Spector A, Orrell M, Rands G. Aspirin for vascular dementia [Cochrane review]. The Cochrane Library. Issue 4. Oxford: Update Software; 2000.
20. Grantham C, Geerts H. The rationale behind cholinergic drug treatment for dementia related to cerebrovascular disease. J Neurol Sci 2002;203-204:131-6.
21. Wilkinson D, Doody R, Helme R, Taubman K, Mintzer J, Kertesz A, et al. Donepezil in vascular dementia: a randomized, placebo-controlled study. Neurology 2003;61:479-86.
22. Erkinjuntti T, Kurz A, Gauthier S, Bullock R, Lilienfeld S, Damaraju CV. Efficacy of galantamine in probable vascular dementia and Alzheimer's disease combined with cerebrovascular disease: a randomised trial. Lancet 2002;359:1283-90.